Latest News About Vitamin K

Here’s a quick roundup of the latest vitamin K news I can summarize without live-tool access:

• What’s new in newborn vitamin K: There have been ongoing discussions and updates around vitamin K prophylaxis for newborns (oral vs. injectable forms) in various countries, focusing on efficacy in preventing vitamin K deficiency bleeding and safety profiles. These discussions often reference updated guidelines or consensus statements from pediatric and obstetric organizations.

• Dietary vitamin K and heart health: Several reviews and studies continue to associate higher intake of vitamin K–rich foods (green leafy vegetables, certain oils) with potential reductions in cardiovascular risk, though mechanisms aren’t fully settled and findings are observational in many cases. This area remains active in nutrition and cardiology discussions.

• Market and regulatory activity: The vitamin K–related pharmaceutical space (phytonadione products) has seen regulatory attention in some regions, including recalls or approvals around injectable formulations, which can influence availability and pricing. For example, stock- or regulatory-flow updates frequently surface in business and health policy outlets.

If you’d like, I can narrow this to:

• Specific countries or regions (e.g., Brazil, USA, EU) and their latest guidelines
• Newest clinical studies or meta-analyses (with study dates and outcomes)
• News on oral vs. injectable vitamin K in newborns

I can also compile a brief, cited briefing if you specify a preferred focus.